Spontaneous tumor formation in Trp53-deficient epidermis mediated by chromosomal instability and inflammation

Anticancer Research

Volumn 29, Issue 8, 2009, Pages 3035-3042

  Martínez Cruz, Ana Belén ^a   Santos, Mirentxu ^a   García Escudero, Ramón ^a   Moral, Marta ^a   Segrelles, Carmen ^a   Lorz, Corina ^a   Saiz, Cristina ^a   Buitrago Pérez, Águeda ^a   Costa, Clotilde ^a   Paramio, Jesús M ^a  

^a CIEMAT   (Spain)

Author keywords

Chromosome instability; Inflammation; Mitotic checkpoint; NF B; Rb; Skin cancer; Trp53

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; EPIDERMIS; GENE; GENE FUNCTION; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TRP53 GENE;

ANIMALS; ANIMALS, NEWBORN; CARCINOMA, SQUAMOUS CELL; CHROMOSOMAL INSTABILITY; GENE EXPRESSION PROFILING; INFLAMMATION; INTEGRASES; MICE; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RETINOBLASTOMA PROTEIN; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 68549096090     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P and Olivier M: Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat 25(6): 622-629, 2007. (Pubitemid 46744292)
2. Toledo F and Wahl GM: Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer 6(12): 909-23.2006.
3. Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M and Berns A: Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet 29(4): 418-425, 2001. (Pubitemid 34326692)
4. Martinez-Cruz AB, Santos M, Lara MF, Segrelles C, Ruiz S, Moral M, Lorz C, Garcia-Escudero R and Paramio JM: Spontaneous squamous cell carcinoma induced by the somatic inactivation of retinoblastoma and Trp53 tumor suppressors. Cancer Res 68(3): 683-692, 2008. (Pubitemid 351206743)
5. García-Escudero R, Martinez-Cruz AB, Santos M, Bielza C, Segrelles C, Moral M, Lorz C, Costa C, Buitrago-Pérez Á, Saiz-Ladera C, Larrañaga P and Paramio JM: Mouse p53-deficient carcinoma models define molecular determinants of metastasis and predict human cancer outcome. Submitted.
6. Ruiz S, Santos M, Lara MF, Segrelles C, Ballestin C and Paramio JM: Unexpected roles for pRb in mouse skin carcinogenesis. Cancer Res 65(21): 9678-9686, 2005. (Pubitemid 41541443)
7. Vaquerizas JM, Conde L, Yankilevich P, Cabezon A, Minguez P, Diaz-Uriarte R, Al-Shahrour F, Herrero J and Dopazo J: GEPAS, an experiment-oriented pipeline for the analysis of microarray gene expression data. Nucleic Acids Res 33(Web Server issue): W616-620, 2005. (Pubitemid 44529996)
8. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U and Speed TP: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4(2): 249-264, 2003.
9. Bolstad BM, Irizarry RA, Astrand M and Speed TP: A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19(2): 185-193, 2003. (Pubitemid 36181903)
10. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V and Quackenbush J: TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34(2): 374-378, 2003. (Pubitemid 36184095)
11. Botchkarev VA, Komarova EA, Siebenhaar F, Botchkareva NV, Sharov AA, Komarov PG, Maurer M, Gudkov AV and Gilchrest BA: p53 Involvement in the control of murine hair follicle regression. Am J Pathol 158(6): 1913-1919, 2001.
12. Komarova EA, Krivokrysenko V, Wang K, Neznanov N, Chernov MV, Komarov PG, Brennan ML, Golovkina TV, Rokhlin OW, Kuprash DV, Nedospasov SA, Hazen SL, Feinstein E and Gudkov AV: p53 is a suppressor of inflammatory response in mice. FASEB J 19(8): 1030-1032, 2005. (Pubitemid 40827741)
13. Fukasawa K, Choi T, Kuriyama R, Rulong S, and Vande Woude GF: Abnormal centrosome amplification in the absence of p53. Science 271(5256): 1744-1747, 1996. (Pubitemid 26102826)
14. Caulin C, Nguyen T, Lang GA, Goepfert TM, Brinkley BR, Cai WW, Lozano G and Roop DR: An inducible mouse model for skin cancer reveals distinct roles for gain- and loss-of-function p53 mutations. J Clin Invest 117(7): 1893-1901, 2007.
15. Wang XJ, Greenhalgh DA, Jiang A, He D, Zhong L, Medina D, Brinkley BR and Roop DR: Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis. Oncogene 17(1): 35-45, 1998. (Pubitemid 28360527)
16. Duensing A and Duensing S: Guilt by association? p53 and the development of aneuploidy in cancer. Biochem Biophys Res Commun 331(3): 694-700, 2005. (Pubitemid 40615499)
17. Fukasawa K: P53, cyclin-dependent kinase and abnormal amplification of centrosomes. Biochim Biophys Acta 1786(1): 15-23, 2008.
18. Lane DP: Exploiting the p53 pathway for the diagnosis and therapy of human cancer. Cold Spring Harb Symp Quant Biol 70: 489-497, 2005. (Pubitemid 44124906)
19. Owens DM and Watt FM: Contribution of stem cells and differentiated cells to epidermal tumours. Nat Rev Cancer 3(6): 444-451, 2003. (Pubitemid 37328848)
20. Lorz C, Segrelles C and Paramio JM: On the origin of epidermal cancers. Curr Mol Med 9(3): 353-364, 2009.
21. Seiberg M, Marthinuss J and Stenn KS: Changes in expression of apoptosis-associated genes in skin mark early catagen. J Invest Dermatol 104(1): 78-82, 1995.
22. Ferris RL and Grandis JR: NF-κB gene signatures and p53 mutations in head and neck squamous cell carcinoma. Clin Cancer Res 13(19): 5663-5664, 2007. (Pubitemid 47583889)
23. Weisz L, Damalas A, Liontos M, Karakaidos P, Fontemaggi G, Maor-Aloni R, Kalis M, Levrero M, Strano S, Gorgoulis VG, Rotter V, Blandino G and Oren M: Mutant p53 enhances nuclear factor κB activation by tumor necrosis factor α in cancer cells. Cancer Res 67(6): 2396-2401, 2007. (Pubitemid 46548921)
24. Scian MJ, Stagliano KE, Anderson MA, Hassan S, Bowman M, Miles MF, Deb SP and Deb S: Tumor-derived p53 mutants induce NF-KB2 gene expression. Mol Cell Biol 25(22): 10097-1110, 2005. (Pubitemid 41572755)
25. Gulati AP, Yang YM, Harter D, Mukhopadhyay A, Aggarwal BB, Benzil DL, Whysner J, Albino AP, Murali R and Jhanwar-Uniyal M: Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-κB, but not c-Jun N-terminal kinase and activated protein-1. Mol Carciriog 45(1): 26-37, 2006.
26. Benoit V, de Moraes E, Dar NA, Taranchon E, Bours V, Hautefeuille A, Taniere P, Chariot A, Scoazec JY, de Moura Gallo CV, Merville MP and Hainaut P: Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-κB. Oncogene 25(42): 5708-5718, 2006. (Pubitemid 44435248)
27. de Moraes E, Dar NA, de Moura Gallo CV and Hainaut P: Cross-talks between cyclooxygenase-2 and tumor suppressor protein p53: Balancing life and death during inflammatory stress and carcinogenesis. Int J Cancer 121(5): 929-937, 2007.
28. Slaga TJ, O'Connell J, Rotstein J, Patskan G, Morris R, Aldaz CM and Conti CJ: Critical genetic determinants and molecular events in multistage skin carcinogenesis. Symp Fundam Cancer Res 39: 31-44, 1986.
29. Aldaz CM, Conti CJ, Larcher F, Trono D, Roop DR, Chesner J, Whitehead T and Slaga TJ: Sequential development of aneuploidy, keratin modifications, and gamma-glutamyltransferase expression in mouse skin papillomas. Cancer Res 48(11): 3253-3257, 1988. (Pubitemid 18141925)
30. Aldaz CM, Conti CJ, Yuspa SH and Slaga TJ: Cytogenetic profile of mouse skin tumors induced by the viral Harvey-ras gene. Carcinogenesis 9(8): 1503-1505, 1988.
31. Tomasini R, Mak TW and Melino G: The impact of p53 and p73 on aneuploidy and cancer. Trends Cell Biol 18(5): 244-252, 2008.
32. Fukasawa K: Centrosome amplification, chromosome instability and cancer development. Cancer Lett 230(1): 6-19, 2005. (Pubitemid 41506955)
33. Tarapore P and Fukasawa K: p53 mutation and mitotic infidelity. Cancer Invest 18(2): 148-155, 2000.
34. Wijnhoven SW, Speksnijder EN, Liu X, Zwart E, Vanoostrom CT, Beems RB, Hoogervorst EM, Schaap MM, Attardi LD, Jacks T, van Steeg H, Jonkers J and de Vries A: Dominant-negative but not gain-of-function effects of a p53.R270H mutation in mouse epithelium tissue after DNA damage. Cancer Res 67(10): 4648-4656, 2007. (Pubitemid 46910169)
35. Ruiz S, Santos M and Paramio JM: Is the loss of pRb essential for mouse skin carcinogenesis? Cell Cycle 5(6): 625-629, 2006.
36. Lara MF, Santos M, Ruiz S, Segrelles C, Moral M, Martinez-Cruz AB, Hernandez P, Martinez-Palacio J, Lorz C, Garcia-Escudero R and Paramio JM: p107 acts as a tumor suppressor in pRb-deficient epidermis. Mol Carcinog 47(2): 105-113, 2008. (Pubitemid 351231439)
37. Santos M, Ruiz S, Lara MF, Segrelles C, Moral M, Martinez-Cruz AB, Ballestin C, Lorz C, Garcia-Escudero R, and Paramio JM: Susceptibility of pRb-deficient epidermis to chemical skin carcinogenesis is dependent on the p107 allele dosage. Mol Carcinog 47(11): 815-821, 2008.
38. Carter SL, Eklund AC, Kohane IS, Harris LN and Szallasi Z: A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 38(9): 1043-1048, 2006.